A Develop Strategy Research Of Pharmaceutical Company S’s CRAM Business

Pharmaceutical industrial is close linked to national economy and the people’s livelihood, and continue growing since the reform and opening-up policy of China. As a subfield of pharmaceutical industrial, small molecular generic drug is booming as well. Pharmaceutical company S, which is specialize in R&D and manufacturing of Activate Pharmaceutical Ingredient(API), is a representative of this industrial. By analyzing the trend of this industrial in domestic and overseas, and integrating the requirement of transformation and upgrading, R&D and manufacturing of peptides new drug is the development direction of company S in future, although it is incapable to take it right now. CRAM business, which includes CRO and CMO, could be a bridge to achieve the longterm target. The assessment of external environment and analysis of competitive capacity of company S are showed in this thesis. Combined with the actual situation of CRAM business, a prognosis is made to present the probable problems during this course. A strategy is given, which comprising optimization of function structure, establishment of efficient project management system, creating an appropriate assessment mechanism of inside and outside, and to build a strategic alliances with customer and vendors, to solve those problems.